Analysis of Brain Protein Stability Changes in a Mouse Model of Alzheimer’s Disease

• Published in: Journal of proteome research 2024-10, Vol.23 (10), p.4443-4456
• Main Authors: Tang, Yun, Park, Hye-Jin, Li, Shengyu, Fitzgerald, Michael C.
• Format: Article
• Language: English
• Subjects: Alzheimer Disease - genetics; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Animals; Brain - metabolism; Brain - pathology; Disease Models, Animal; Hippocampus - metabolism; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Oxidation-Reduction; Proteasome Endopeptidase Complex - metabolism; Protein Folding; Protein Stability; Proteolysis; Proteome - analysis; Proteome - metabolism; Proteomics - methods
• ISSN: 1535-3893; 1535-3907; 1535-3907
• DOI: 10.1021/acs.jproteome.4c00406

The stability of proteins from rates of oxidation (SPROX), thermal proteome profiling (TPP), and limited proteolysis (LiP) techniques were used to profile the stability of ∼2500 proteins in hippocampus tissue cell lysates from 2- and 8-months-old wild-type (C57BL/6J; n = 7) and transgenic (5XFAD; n = 7) mice with five Alzheimer’s disease (AD)-linked mutations. Approximately 200–500 protein hits with AD-related stability changes were detected by each technique at each age point. The hit overlap from technique to technique was low, and all of the techniques generated protein hits that were more numerous and largely different from those identified in protein expression level analyses, which were also performed here. The hit proteins identified by each technique were enriched in a number of the same pathways and biological processes, many with known connections to AD. The protein stability hits included 25 high-value conformation biomarkers with AD-related stability changes detected using at least 2 techniques at both age points. Also discovered were subunit- and age-specific AD-related stability changes in the proteasome, which had reduced function at both age points. The different folding stability profiles of the proteasome at the two age points are consistent with a different mechanism for proteasome dysfunction at the early and late stages of AD.